5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.74▲ | 1.77▲ | 1.79▼ | 1.57▲ | 1.20▲ |
MA10 | 1.77▲ | 1.82▼ | 1.76▲ | 1.26▲ | 1.19▲ |
MA20 | 1.77▲ | 1.75▲ | 1.65▲ | 1.11▲ | 1.55▲ |
MA50 | 1.78▼ | 1.65▲ | 1.40▲ | 1.22▲ | 2.07▼ |
MA100 | 1.67▲ | 1.36▲ | 1.17▲ | 1.63▲ | 2.44▼ |
MA200 | 1.61▲ | 1.16▲ | 1.15▲ | 2.11▼ | 5.78▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.013▼ | -0.004▼ | 0.107▲ | 0.033▲ |
RSI | 49.753▼ | 54.803▲ | 59.398▲ | 72.764▲ | 51.892▲ |
STOCH | 25.269 | 30.500 | 64.607 | 78.405 | 26.475 |
WILL %R | -45.161 | -52.381 | -33.673 | -17.215▲ | -19.618▲ |
CCI | 5.537 | -41.437 | 37.142 | 144.815▲ | 106.017▲ |
Thursday, June 26, 2025 05:11 AM
Short interest in VYNE Therapeutics Inc (NASDAQ:VYNE) increased during the last reporting period, rising from 123.20K to 139.81K. This put 0.96% of the company's publicly available shares short ...
|
Friday, April 25, 2025 05:13 AM
VYNE Therapeutics Inc. has announced that the FDA has placed a clinical hold on its Phase 1b study of VYN202 for moderate-to-severe plaque psoriasis due to observed testicular toxicity in dogs ...
|
Friday, April 25, 2025 02:25 AM
Vyne Therapeutics’ attempt to develop a safer, more tolerable BET inhibitor has hit turbulence. The FDA slapped a clinical hold on a phase 1b plaque psoriasis trial after testicular toxicity was ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 1.65 | 1.96 | 1.641 | 1.77 | 1,855,597 |
30/06/25 | 1.47 | 1.69 | 1.45 | 1.65 | 1,044,758 |
27/06/25 | 1.62 | 1.72 | 1.40 | 1.42 | 1,231,175 |
26/06/25 | 1.39 | 1.75 | 1.365 | 1.62 | 4,948,711 |
25/06/25 | 1.10 | 1.59 | 1.08 | 1.37 | 7,430,663 |
24/06/25 | 0.9274 | 1.11 | 0.92 | 1.06 | 1,028,913 |
23/06/25 | 0.89 | 0.93 | 0.89 | 0.9141 | 157,770 |
20/06/25 | 0.965 | 0.965 | 0.8563 | 0.89 | 411,756 |
18/06/25 | 0.94 | 0.96 | 0.902 | 0.9404 | 152,697 |
17/06/25 | 0.92 | 0.948 | 0.89 | 0.9186 | 176,178 |
|
|
||||
|
|
||||
|
|